January 10, 2025 - 13:34

Shares of major Indian IT outsourcing firms, including Infosys Ltd., HCL Technologies Ltd., and Wipro Ltd., have experienced a notable increase following Donald Trump's victory in the US presidential election. This surge reflects investor optimism regarding the potential impacts of his administration on the technology sector and outsourcing landscape.
As these companies prepare to release their earnings reports, they will have the opportunity to discuss their business outlook in light of the new political climate. Analysts are particularly interested in how Trump's policies on immigration, trade, and technology will influence the operations and growth prospects of these firms.
The Indian IT sector has long been a significant player in the global market, and the upcoming earnings calls are expected to provide valuable insights into how these companies plan to navigate the challenges and opportunities presented by the Trump presidency. Investors and industry stakeholders are keenly awaiting the commentary from these firms to gauge their strategies moving forward.
March 18, 2026 - 11:16
Five Key Takeaways from a Weekend Coding Class for Non-Technical MindsThe idea of building an app in a single weekend seemed like a distant fantasy, something reserved for seasoned developers. Yet, a recent weekend `vibe coding` class made that a tangible reality,...
March 17, 2026 - 21:39
Orange Bank & Trust Company Celebrates Women’s Leadership at Annual Bronx Women in Business EventOrange Bank & Trust Company recently hosted its second annual Bronx Women in Business event, a vibrant celebration of female entrepreneurship and leadership within the borough. The gathering...
March 17, 2026 - 04:07
Autonomous businesses – from Waymo to mattress stores – are on the riseThe familiar chime of a door opening to reveal an empty room is becoming an increasingly common retail experience. From driverless taxis to fully automated mattress showrooms, autonomous businesses...
March 16, 2026 - 18:22
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsCue Biopharma has released its financial and operational results for the fourth quarter and full year ending 2025, detailing a period marked by strategic pipeline advancement and key corporate...